Liver solitary fibrous tumor
diseaseOn this page
Also known as fibroma of liverfibroma of the liverhepatic fibromaliver fibromaliver localised fibrous mesotheliomaliver localised fibrous tumourliver localized fibrous mesotheliomaliver localized fibrous tumor
Summary
Liver solitary fibrous tumor (MONDO:0004705) is a cancer. A subtype of fibroma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | liver solitary fibrous tumor |
| Mondo ID | MONDO:0004705 |
| DOID | DOID:907 |
| NCIT | C5752 |
| UMLS | C1333965 |
| MedGen | 232273 |
| GARD | 0024092 |
| Anatomy (UBERON) | UBERON:0002107 |
| Is cancer (heuristic) | yes |
Also known as: fibroma of liver · fibroma of the liver · hepatic fibroma · liver fibroma · liver localised fibrous mesothelioma · liver localised fibrous tumour · liver localized fibrous mesothelioma · liver localized fibrous tumor · liver solitary fibrous tumor
Disease family
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › mesenchymal cell neoplasm › fibroblastic neoplasm › fibroma › liver solitary fibrous tumor
Related subtypes (10): testicular fibroma, serous cystadenofibroma, adenofibroma, tendon sheath fibroma, uterine corpus leiomyoma, ovarian fibroma, calcified aponeurotic fibroma, fibroma of lung, fibroma of prostate, oral fibroma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.